In our cohort, pancreatic cancer showed a relative increase in MLH1 carriers only, in line with the most recent prospective study showing a cumulative risk of 6.2% for pancreas cancer in MLH1 carriers only [7]. Here, MLH1 is linked to familial pancreatic carcinoma.